{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:57:07Z","timestamp":1718618227595},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cerebral venous sinus thrombosis (CVST) is typically associated with a prothrombotic state of the blood, with its causative factors varying widely. Prior research has not reported the simultaneous occurrence of CVST and dural arteriovenous fistulas (DAVFs) as potentially resulting from genetic mutations. In this case report, we introduce a unique occurrence wherein a patient with a heterozygous mutation of the low-density lipoprotein receptor (<jats:italic>LDLR)<\/jats:italic> gene presented with CVST in conjunction with DAVFs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case<\/jats:title>\n                <jats:p>P<jats:bold>resentation<\/jats:bold>: A male patient, aged 51, sought treatment at our facility due to a consistent decline in cognitive functions accompanied by recurrent headaches. Comprehensive evaluations were administered, including neurological examinations, laboratory tests, magnetic resonance imaging, digital subtraction angiography, and whole exome sequencing. Digital subtraction angiography identified DAVFs in the patient\u2019s right sigmoid sinus and an occlusion within the left transverse sinus. The whole exome sequencing of blood samples pinpointed a heterozygous mutation in the <jats:italic>LDLR<\/jats:italic> gene (NM_000527:exon12:c.C1747T:p.H583Y). Following the confirmed diagnosis of CVST and DAVFs, the patient underwent anticoagulant therapy combined with endovascular procedures \u2014 these comprised embolization of the arteriovenous fistula in the right sigmoid sinus and balloon dilation with stent implantation in the left transverse sinus. A six-month follow-up indicated a significant abatement in the patient\u2019s symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This report marks the first documented case of an <jats:italic>LDLR<\/jats:italic> gene mutation that could be associated with the onset of CVST and DAVFs. The mutation in the <jats:italic>LDLR<\/jats:italic> gene might foster a prothrombotic environment, facilitating the gradual emergence of CVST and the subsequent genesis of DAVFs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03455-5","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T06:01:56Z","timestamp":1701151316000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of LDLR mutation in cerebral venous sinus thrombosis co-existing with dural arteriovenous fistulas: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Qing-hua","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-quan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-ling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"issue":"3","key":"3455_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1552-6569.2001.tb00055.x","volume":"11","author":"V Singh","year":"2001","unstructured":"Singh V, Meyers PM, Halbach VH, Gress DR, Higashida RT, Dowd CF, et al. Dural arteriovenous fistula associated with prothrombin gene mutation. J Neuroimaging. 2001;11(3):319\u201321. https:\/\/doi.org\/10.1111\/j.1552-6569.2001.tb00055.x.","journal-title":"J Neuroimaging"},{"issue":"4","key":"3455_CR2","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD Jr., Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous Thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(4):1158\u201392. https:\/\/doi.org\/10.1161\/STR.0b013e31820a8364.","journal-title":"Stroke"},{"issue":"6","key":"3455_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3174\/ajnr.A2798","volume":"33","author":"D Gandhi","year":"2012","unstructured":"Gandhi D, Chen J, Pearl M, Huang J, Gemmete JJ, Kathuria S. Intracranial dural arteriovenous fistulas: classification, imaging findings, and treatment. AJNR. J Neuroradiol. 2012;33(6):1007\u201313. https:\/\/doi.org\/10.3174\/ajnr.A2798. Am.","journal-title":"J Neuroradiol"},{"issue":"25","key":"3455_CR4","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1182\/blood-2010-03-277079","volume":"116","author":"N Martinelli","year":"2010","unstructured":"Martinelli N, Girelli D, Lunghi B, Pinotti M, Marchetti G, Malerba G, et al. Polymorphisms at LDLR locus may be associated with coronary artery Disease through modulation of coagulation factor VIII activity and independently from lipid profile. Blood. 2010;116(25):5688\u201397. https:\/\/doi.org\/10.1182\/blood-2010-03-277079.","journal-title":"Blood"},{"issue":"3","key":"3455_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/156720212801618965","volume":"9","author":"JD Lee","year":"2012","unstructured":"Lee JD, Lee TH, Kuo YW, Huang YC, Hsu HL, Lin YH, et al. Polymorphisms at the LDLR locus may be associated with ischemic Cerebrovascular Disease Independent of lipid profile. Curr Neurovasc Res. 2012;9(3):200\u20136. https:\/\/doi.org\/10.2174\/156720212801618965.","journal-title":"Curr Neurovasc Res"},{"issue":"9","key":"3455_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/gtmb.2018.0058","volume":"22","author":"A Alsultan","year":"2018","unstructured":"Alsultan A, Al-Suliman AM, Aleem A, AlGahtani FH, Alfadhel M. Utilizing whole-exome sequencing to characterize the phenotypic variability of Sickle Cell Disease. Genet Test Mol Biomarkers. 2018;22(9):561\u20137. https:\/\/doi.org\/10.1089\/gtmb.2018.0058.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"8943","key":"3455_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/s0140-6736(95)90166-3","volume":"345","author":"T Koster","year":"1995","unstructured":"Koster T, Blann AD, Bri\u00ebt E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of Von Willebrand factor on occurrence of deep-vein Thrombosis. Lancet. 1995;345(8943):152\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(95)90166-3.","journal-title":"Lancet"},{"issue":"7","key":"3455_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/nejm200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343(7):457\u201362. https:\/\/doi.org\/10.1056\/nejm200008173430702.","journal-title":"N Engl J Med"},{"issue":"3","key":"3455_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1182\/blood-2004-11-4230","volume":"106","author":"N Bovenschen","year":"2005","unstructured":"Bovenschen N, Mertens K, Hu L, Havekes LM, van Vlijmen BJ. LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo. Blood. 2005;106(3):906\u201312. https:\/\/doi.org\/10.1182\/blood-2004-11-4230.","journal-title":"Blood"},{"issue":"1","key":"3455_CR10","doi-asserted-by":"publisher","first-page":"e0146990","DOI":"10.1371\/journal.pone.0146990","volume":"11","author":"E Ochoa","year":"2016","unstructured":"Ochoa E, Iriondo M, Manzano C, Fullaondo A, Villar I, Ruiz-Irastorza G, et al. LDLR and PCSK9 are Associated with the Presence of Antiphospholipid antibodies and the development of Thrombosis in aPLA. Carriers PLoS One. 2016;11(1):e0146990. https:\/\/doi.org\/10.1371\/journal.pone.0146990.","journal-title":"Carriers PLoS One"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03455-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T06:02:17Z","timestamp":1701151337000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03455-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03455-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient to publish this case report. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"423"}}